- API
Any substance that is represented for use in a drug and that, when used in the manufacturing, processing, or packaging ...
- Active Ingredient
Any component that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, ...
- CAS No.
Unique number assigned to a specific chemical (identified by its chemical name) by the American Chemical Society and ...
Yohimbine
Catalog No. | PI0148 |
---|---|
CAS No. | 146-48-5 |
Molecular Formula | C21H26N2O3 |
Molecular Weight | 354.45 |
Purity | 8% HPLC |
Package | 25 kg |
Botanical Source | Corynanthe yohimbe |
Appearance | Powder |
Shelf Life | 2 years |
Note: This yohimbine can also be used as reference standards. You can find it under the category of Reference Substance at Herbalext.com. |
Safety Tips of Yohimbine
Handling of yohimbine should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes.
Related Products
-
Catalog No.: HE0003
Specification: 25% Polysaccharides UV
Package: 25 kg/drum
Botanical Source: Achyranthes Bidentata
Related Researches
- 1. Non-Antidepressant Psychopharmacologic Treatment of Specific Phobias.
Khalil RB. Curr Clin Pharmacol 2013 Feb 4.
- 2. Synthesis of 2,4-dihydroxychalcone derivatives as potential antidepressant effect.
Guan LP, et al. Drug Res (Stuttg) 2013 Jan;63(1):46-51.
- 3. [Intraventricular yohimbine infusion induces noradrenergic changes in motor cerebral injured rats and enhances motor recovery].
González-Piña R, et al. Cir Cir 2013 Jan-Feb;81(1):28-32. Spanish.
- 4. Lateral reticular nucleus modulates the cardiosomatic reflex evoked by intrapericardial capsaicin in the rat.
Han M, et al. Eur J Neurosci 2013 May;37(9):1511-8.
- 5. Ethopharmacological analysis of the open elevated plus-maze in mice.
Sorregotti T, et al. Behav Brain Res 2013 Jun 1;246:76-85.
- 6. Rho-Kinase activity and cutaneous vasoconstriction is upregulated in essential hypertensive humans.
Smith CJ, et al. Microvasc Res 2013 May;87:58-64.
- 7. α2-Adrenergic agonists including xylazine and dexmedetomidine inhibit norepinephrine transporter function in SK-N-SH cells.
Park JW, et al. Neurosci Lett 2013 Apr 29;541:184-9.
- 8. Enhanced noradrenergic activity potentiates fear memory consolidation and reconsolidation by differentially recruiting α1- and β-adrenergic receptors.
Gazarini L, et al. Learn Mem 2013 Mar 19;20(4):210-9.
- 9. Mechanisms involved in the antinociceptive effects of orally administered oleanolic acid in the mouse.
Park SH, et al. Arch Pharm Res 2013 Mar 21.
- 10. Effect of phenylephrine on alveolar fluid clearance in ventilator-induced lung injury.
Li NJ, et al. Chin Med Sci J 2013 Mar;28(1):1-6.